90380563 - SAMSUNG BIOLOGICS

Information

  • Trademark
  • 90380563
  • Serial Number
    90380563
  • Registration Number
    7102687
  • Filing Date
    December 14, 2020
    3 years ago
  • Registration Date
    July 11, 2023
    9 months ago
  • Transaction Date
    July 11, 2023
    9 months ago
  • Status Date
    July 11, 2023
    9 months ago
  • Published for Opposition Date
    April 25, 2023
    12 months ago
  • Location Date
    July 11, 2023
    9 months ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MEIER, SHARON A
  • Attorney Docket Number
    220812
    Attorney Name
    Diane J. Mason
    Law Office Assigned Location Code
    M30
  • Owners
Mark Drawing Code
4000
Mark Identification
SAMSUNG BIOLOGICS
Case File Statements
  • GS0401: Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; Production of cell lines for use in the manufacture of biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials, namely, custom manufacturing of pharmaceuticals; Custom manufacture of pharmaceuticals for others; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicals
  • GS0051: Bouillons for bacteriological cultures; biological reagents for veterinary purposes; biological tissue cultures for veterinary purposes; diagnostic test reagents for medical or veterinary purposes; in vitro diagnostic preparations for medical purposes; biological preparations for medical or veterinary purposes for the prevention and treatment of infectious diseases; reagents and media for medical and veterinary diagnostic purposes; cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical and veterinary use; cultures for medical use, namely, bacteriological cultures for medical purposes; biological reagents for medical purposes; biological tissue cultures for medical purposes; stem cells for medical purposes; stem cells for medical, pharmaceutical or veterinary use; surgical implants grown from stem cells being living tissues; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; radioisotope markers for therapeutic or diagnostic use
  • GS0011: Enzymes derived from biotechnological processes for use in industry; cell growth media for growing cells for use in scientific research; stem cells for scientific purposes; cells for scientific or laboratory purposes; preparations for gene recombination for scientific or laboratory purposes; synthetic gene for research other than for medical purposes; chemicals for use in biotechnological product development; biological preparations for use in biotechnology other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; probiotic bacterial cultures for the food industry; stem cells for research purposes; chemical reagents for use in genetic research; chemical reagents for genetic identity testing for non-medical purposes; stem cells other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purpose; reagents for use in scientific apparatus for chemical or biological analysis
  • TR0010: The English translation of "SAMSUNG" in the mark is "three stars".
  • D10000: "BIOLOGICS"
  • GS0421: Microbial culture trials; research and development of technology for biotechnology; crude medicines research, namely, Herbal medicine research; biochemistry research services; bacteriological research and analysis; development of cell therapy products; development of pharmaceutical preparations and medicines; pharmaceutical products development; inspection of pharmaceuticals; research relating to pharmaceuticals; clinical testing of medicines; pharmaceutical products evaluation; scientific research in the field of genetic engineering; Genetic research for scientific purposes; medical laboratories; Medical research of medicines; research for medical products; Conducting clinical trials for others; stem cell research services
Case File Event Statements
  • 7/11/2023 - 9 months ago
    26 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 7/11/2023 - 9 months ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/25/2023 - 12 months ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/25/2023 - 12 months ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/5/2023 - a year ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/21/2023 - a year ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/13/2023 - a year ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/13/2023 - a year ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/11/2023 - a year ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 12/29/2022 - a year ago
    17 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 7/15/2022 - a year ago
    16 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 7/11/2022 - a year ago
    15 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 7/11/2022 - a year ago
    14 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 7/11/2022 - a year ago
    13 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 1/3/2022 - 2 years ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 1/3/2022 - 2 years ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 1/3/2022 - 2 years ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/14/2021 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/14/2021 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/14/2021 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/18/2021 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/18/2021 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/18/2021 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/5/2021 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/22/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/17/2020 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP